EP4370501A1 - Method of preparing of arthropodicidal oxadiazine intermediate - Google Patents
Method of preparing of arthropodicidal oxadiazine intermediateInfo
- Publication number
- EP4370501A1 EP4370501A1 EP22751859.4A EP22751859A EP4370501A1 EP 4370501 A1 EP4370501 A1 EP 4370501A1 EP 22751859 A EP22751859 A EP 22751859A EP 4370501 A1 EP4370501 A1 EP 4370501A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- formula
- compound
- preparation
- process according
- phosgene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 60
- QMEQBOSUJUOXMX-UHFFFAOYSA-N 2h-oxadiazine Chemical compound N1OC=CC=N1 QMEQBOSUJUOXMX-UHFFFAOYSA-N 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 49
- 238000002360 preparation method Methods 0.000 claims abstract description 46
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000006243 chemical reaction Methods 0.000 claims abstract description 29
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 20
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 20
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 20
- 239000003960 organic solvent Substances 0.000 claims abstract description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 18
- XMTCQQIMRUZNCL-UHFFFAOYSA-N methyl n-carbonochloridoyl-n-[4-(trifluoromethoxy)phenyl]carbamate Chemical compound COC(=O)N(C(Cl)=O)C1=CC=C(OC(F)(F)F)C=C1 XMTCQQIMRUZNCL-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000003444 phase transfer catalyst Substances 0.000 claims abstract description 17
- 229910052987 metal hydride Inorganic materials 0.000 claims abstract description 15
- 150000004681 metal hydrides Chemical class 0.000 claims abstract description 15
- 150000007530 organic bases Chemical class 0.000 claims abstract description 14
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000005907 Indoxacarb Substances 0.000 claims abstract description 8
- 238000004821 distillation Methods 0.000 claims abstract description 8
- VBCVPMMZEGZULK-NRFANRHFSA-N indoxacarb Chemical compound C([C@@]1(OC2)C(=O)OC)C3=CC(Cl)=CC=C3C1=NN2C(=O)N(C(=O)OC)C1=CC=C(OC(F)(F)F)C=C1 VBCVPMMZEGZULK-NRFANRHFSA-N 0.000 claims abstract description 8
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 23
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 239000011541 reaction mixture Substances 0.000 claims description 5
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 claims description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 claims description 4
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 239000008096 xylene Substances 0.000 claims description 4
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 claims description 3
- 150000003983 crown ethers Chemical class 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 claims description 2
- HWCKGOZZJDHMNC-UHFFFAOYSA-M tetraethylammonium bromide Chemical compound [Br-].CC[N+](CC)(CC)CC HWCKGOZZJDHMNC-UHFFFAOYSA-M 0.000 claims description 2
- DDFYFBUWEBINLX-UHFFFAOYSA-M tetramethylammonium bromide Chemical compound [Br-].C[N+](C)(C)C DDFYFBUWEBINLX-UHFFFAOYSA-M 0.000 claims description 2
- BGQMOFGZRJUORO-UHFFFAOYSA-M tetrapropylammonium bromide Chemical compound [Br-].CCC[N+](CCC)(CCC)CCC BGQMOFGZRJUORO-UHFFFAOYSA-M 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 125000002490 anilino group Chemical class [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 239000012948 isocyanate Substances 0.000 abstract 1
- 150000002513 isocyanates Chemical class 0.000 abstract 1
- GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical compound COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 description 28
- 239000000543 intermediate Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- 239000003929 acidic solution Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003849 aromatic solvent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 150000005063 oxadiazines Chemical class 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
- C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
- C07D273/04—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
- C07C271/66—Y being a hetero atom
Definitions
- the present invention concerns a process for preparing of methyl chloroformyl[4- (trifluoromethoxy)phenyl]carbamate as key intermediate for preparation of indoxacarb in the absence of organic base and metal hydride.
- Arthropodicidal oxadiazines and the corresponding synthetic methods for the preparation of biologically active oxadiazines and their intermediates are previously disclosed in patent applications WO 9211249, WO 95/29171 and WO 9319045.
- the present invention provides a process for preparation of methyl chloroformyl[4- (trifluoromethoxy)phenyl]carbamate of formula I comprising reaction of compound of formula (IV) with phosgene or phosgene derivative in the presence of phase transfer catalyst, alkaline base and hydrocarbon organic solvent and in the absence of organic base and metal hydride.
- the present invention provides a telescopic process for preparation of methyl chloroformyl[4-(trifluoromethoxy)phenyl]carbamate of formula I comprising: a) preparation of compound of formula (II) by reaction of compound of formula (III) with phosgene or phosgene derivative in the presence of dimethylcarbonate and hydrocarbon organic solvent b) preparation of compound of formula (IV) by reaction of compound of formula (II) with methanol and distillation out of dimethylcarbonate c) reaction of compound of formula (IV) with phosgene or phosgene derivative in the presence of phase transfer catalyst, alkaline base and hydrocarbon organic solvent.
- the present invention further provides a process of preparation of indoxacarb of formula V using methyl chloroformyl[4-(trifluoromethoxy)phenyl]carbamate of formula (I) prepared by process , comprising reaction of compound of formula (IV) with phosgene in the presence of phase transfer catalyst, alkaline base and hydrocarbon organic solvent and in the absence of organic base and metal hydride.
- Certain compounds of this invention can exist as one or more stereoisomers.
- the various stereoisomers include enantiomers, diastereomers, and geometric isomers.
- one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s). Additionally, the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers.
- the compounds of the invention may be present as a mixture of stereoisomers, individual stereoisomers, or as an optically active form.
- telescopic process refers to carrying out several reactions without isolating the intermediate products.
- telescopic process suggests the execution of multiple transformations (including reaction quenches and other workup operations) without the direct isolation of intermediates.
- Telescoped solutions of intermediates can be extracted, filtered (as long as the desired product remains in the filtrate), and solvent exchanged, but the intermediate is ultimately held in solution and carried forward to the subsequent transformation.
- the present invention provides technology useful for the successful and convenient preparation of methyl chloroformyl[4-(trifluoromethoxy)phenyl]carbamate of formula (I) as intermediate for synthesis of indoxacarb of formula V in the absence of organic base and metal hydride.
- the present invention concerns the process for preparation of methyl chloroformyl[4-(trifluoromethoxy)phenyl]carbamate of formula I comprising reaction of compound of formula (IV) with phosgene or phosgene derivative in the presence of phase transfer catalyst, alkaline base and hydrocarbon organic solvent and in the absence of organic base and metal hydride.
- phosgene derivative is selected from diphosgene, triphosgene or the mixtures thereof.
- the process carried out "in the absence of organic base” refers to the process including not more than 0.01 mole of organic base on each 1 mole of carbamic acid methyl ester of formula (IV).
- the process carried out "in the absence of organic base” refers to the process including not more than 0.05 mole of organic base on each 1 mole of carbamic acid methyl ester of formula (IV). In some embodiment, the process carried out “in the absence of organic base” refers to the process including not more than 0.1 mole of organic base on each 1 mole of carbamic acid methyl ester of formula (IV).
- the process carried out "in the absence of metal hydride” refers to the process including not more than 0.01 mole of metal hydride on each 1 mole of carbamic acid methyl ester of formula (IV).
- the process carried out "in the absence of metal hydride” refers to the process including not more than 0.05 mole of metal hydride on each 1 mole of carbamic acid methyl ester of formula (IV). In some embodiment, the process carried out “in the absence of metal hydride” refers to the process including not more than 0.1 mole of metal hydride on each 1 mole of carbamic acid methyl ester of formula (IV).
- the process is suitably carried out in hydrocarbon organic solvent such as hexane, petroleum ether, toluene, chlorobenzene, xylene, mesitylene and the mixtures thereof.
- hydrocarbon organic solvent such as hexane, petroleum ether, toluene, chlorobenzene, xylene, mesitylene and the mixtures thereof.
- the process pertains the alkaline base such as sodium hydroxide, potassium hydroxide, potassium carbonate, sodium carbonate and the mixtures thereof.
- the process concerns the presence of sodium hydroxide, potassium hydroxide or the mixtures thereof.
- the amount of alkaline base used in the process is 1.0 to 10.0 mole as related to 1 mole of carbamic acid methyl ester of formula (IV).
- the amount of sodium hydroxide base used in the process is 6.0 mole as related to 1 mole of carbamic acid methyl ester of formula (IV).
- the process pertains the presence of phase transfer catalyst, such as tetra-butyl ammonium iodide, tetra-ethyl ammonium bromide, tetra-methyl ammonium bromide, tetra-propyl ammonium bromide, tetra-butyl ammonium bromide, crown ethers, PEG and the mixtures thereof.
- the amount of phase transfer catalyst used in the process is 0.001 to 0.1 mole as related to 1 mole of carbamic acid methyl ester of formula (IV).
- the amount of phase transfer catalyst used in the process is 0.05mole as related to 1 mole of carbamic acid methyl ester of formula (IV).
- phase transfer catalyst is tetra-butyl ammonium bromide (TBAB).
- the compound of formula (II) is not isolated from the reaction mixture.
- the present invention concerns the telescopic process for preparation of methyl chloroformyl[4-(trifluoromethoxy)phenyl]carbamate of formula I comprising: a) preparation of compound of formula (II) by reaction of compound of formula (III) with phosgene or phosgene derivative in the presence of dimethylcarbonate and hydrocarbon organic solvent b) preparation of compound of formula (IV) by reaction of compound of formula (II) with methanol and distillation out of dimethylcarbonate c) reaction of compound of formula (IV) with phosgene or phosgene derivative in the presence of phase transfer catalyst, alkaline base and hydrocarbon organic solvent.
- the hydrocarbon organic solvent is selected from the group consisting of toluene, chlorobenzene, xylene, mesitylene and the mixtures thereof.
- the preparation of compound of formula (II) is carried out at a temperature of from 10°C to 70 °C. In a class of this embodiment the preparation of compound of formula (II) is carried out at a temperature of 25 to 70°C.
- process comprising from 0.0 : 1.0 to 0.84 : 1.0 mole ratio of dimethyl carbonate/ chlorobenzene.
- the preparation of compound of formula (III) is carried out at a temperature of from 10°C to 70 °C.
- the preparation of compound of formula (IV) is carried out at a temperature of from 0°C to 80°C. In a further embodiment the preparation of compound of formula (I) is carried out at a temperature of from 0°C to 80°C.
- the desired product, a compound of Formula V can be isolated by methods known to those skilled in the art, including crystallization, extraction and distillation.
- the present invention concerns the preparation of indoxacarb of formula V using methyl chloroformyl[4-(trifluoromethoxy)phenyl]carbamate of formula I prepared by the telescopic process comprising: a) preparation of compound of formula (II) by reaction of compound of formula (III) with phosgene in the presence of dimethylcarbonate and hydrocarbon organic solvent b) preparation of compound of formula (IV) by reaction of compound of formula (II) with methanol and distillation out of dimethylcarbonate c) reaction of compound of formula (IV) with phosgene in the presence or phosgene derivative of phase transfer catalyst, alkaline base and hydrocarbon organic solvent as described in previous embodiments.
- the desired product, a compound of Formula I can be isolated by methods known to those skilled in the art, including crystallization, extraction and distillation.
- the experimental set-up involved two syringe pumps followed by a micromixer, which was then connected to a coiled PFA tube (0.8 mm i.d., 3.65 mL volume). The residence time was varied by changing the flow rates. The samples were collected in acidic solution to quench the reaction at the outlet of the reaction tube. The product was subjected to analysis after further dilution.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163221016P | 2021-07-13 | 2021-07-13 | |
PCT/IL2022/050743 WO2023286053A1 (en) | 2021-07-13 | 2022-07-11 | Method of preparing of arthropodicidal oxadiazine intermediate |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4370501A1 true EP4370501A1 (en) | 2024-05-22 |
Family
ID=82846551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP22751859.4A Pending EP4370501A1 (en) | 2021-07-13 | 2022-07-11 | Method of preparing of arthropodicidal oxadiazine intermediate |
Country Status (5)
Country | Link |
---|---|
US (1) | US20240327363A1 (zh) |
EP (1) | EP4370501A1 (zh) |
CN (1) | CN117940402A (zh) |
IL (1) | IL309820A (zh) |
WO (1) | WO2023286053A1 (zh) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5462938A (en) | 1990-12-21 | 1995-10-31 | Annus; Gary D. | Arthropodicidal oxadiazinyl, thiadiazinyl and triazinyl carboxanilides |
WO1993019045A1 (en) | 1992-03-26 | 1993-09-30 | E.I. Du Pont De Nemours And Company | Arthropodicidal amides |
CN1142922C (zh) | 1994-04-20 | 2004-03-24 | 纳幕尔杜邦公司 | 用于制备噁二嗪的中间体及其制法 |
CN112479934A (zh) * | 2020-12-09 | 2021-03-12 | 安徽广信农化股份有限公司 | 一种氨基氯甲酸甲酯的合成方法 |
-
2022
- 2022-07-11 US US18/578,908 patent/US20240327363A1/en active Pending
- 2022-07-11 WO PCT/IL2022/050743 patent/WO2023286053A1/en active Application Filing
- 2022-07-11 CN CN202280049071.3A patent/CN117940402A/zh active Pending
- 2022-07-11 EP EP22751859.4A patent/EP4370501A1/en active Pending
- 2022-07-11 IL IL309820A patent/IL309820A/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20240327363A1 (en) | 2024-10-03 |
WO2023286053A1 (en) | 2023-01-19 |
IL309820A (en) | 2024-02-01 |
CN117940402A (zh) | 2024-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2393148C2 (ru) | Способ получения (s)-3-[(1-диметиламино)этил]-фенил-n-этил-n-метил-карбамата | |
EA017568B1 (ru) | Способ получения циклогексанона с удалением примесей | |
WO2006092429A1 (de) | Verfahren zur herstellung substituierter biphenyle | |
EP2265571A1 (de) | Verfahren zur herstellung von urethanen aus mono- und difunktionalen aromatischen aminen | |
US6504044B2 (en) | Process for the preparation of 1-[cyano(aryl)methyl] cyclohexanol | |
EP1674448B1 (en) | Process for producing cyclohexanone oxime | |
WO2023286053A1 (en) | Method of preparing of arthropodicidal oxadiazine intermediate | |
US6392064B2 (en) | Method of synthesizing glycidyl ether compounds in the absence of water and organic solvents | |
EP2265572B1 (de) | Metallcarbamate aus diaminophenylmethan | |
CN113956157B (zh) | 一种合成2-甲酰基-1-环丙烷甲酸乙酯的方法 | |
JPS6242896B2 (zh) | ||
KR100288098B1 (ko) | 요오도프로파르길 카르바메이트의 제조 방법 | |
CN101260068A (zh) | 制备4-(4′-氨基苯基亚甲基)苯氨基甲酸甲酯的方法 | |
CN110668958B (zh) | 一种制备(r)-3-氨基丁醇的方法 | |
KR20140039306A (ko) | 알킬디올모노글리시딜에테르의 제조 방법 | |
CN102164886A (zh) | 用于制备o-去甲文拉法辛的方法 | |
CN101679210B (zh) | 旋光性α氨基乙缩醛外消旋化的方法 | |
CN107778178B (zh) | 一种制备顺丁烯二酸单苯酯的方法 | |
CN114890975B (zh) | 一种并环色满结构化合物及制备方法 | |
DE4225763A1 (de) | Verfahren zur Herstellung von Halogenaromaten | |
JPH0417947B2 (zh) | ||
US4014867A (en) | Production of hexamethyleneimine from caprolactam | |
CN108069836B (zh) | 一种制备三(3,6-二氧杂庚基)胺的新方法 | |
Wei et al. | Stereoselective synthesis of (E)-β-aryloxyl and alkyloxyl acrylates through DABCO-catalysed Michael additions of phenols and alcohols to ethyl 2, 3-butadienoate | |
CN114436851A (zh) | 一种n,n-二甲基苄胺及其衍生物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20240209 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |